Evidence map›Paper›PMID 36097420›Full record

ArticleANZ journal of surgery2022

Opioid use and patient outcomes in an Australian hip and knee arthroplasty cohort.

Phil Huang, Jack Brownrigg, Justin Roe, David Carmody, Leo Pinczewski, Benjamin Gooden, Matthew Lyons, Lucy Salmon, Ka Martina, Joanna Crighton and 1 more

Open access · hybridAbstract read
In one paragraph

Article in ANZ journal of surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Phil HuangNorth Sydney Orthopaedic Research Group, Sydney, New South Wales, Australia.
Jack BrownriggSchool of Medicine, University of Notre Dame, Sydney, New South Wales, Australia.
Justin RoeNorth Sydney Orthopaedic Research Group, Sydney, New South Wales, Australia.
David CarmodyNorth Sydney Orthopaedic Research Group, Sydney, New South Wales, Australia.
Leo PinczewskiNorth Sydney Orthopaedic Research Group, Sydney, New South Wales, Australia.ORCID 0000-0002-2685-5109
Benjamin GoodenNorth Sydney Orthopaedic Research Group, Sydney, New South Wales, Australia.
Matthew LyonsNorth Sydney Orthopaedic Research Group, Sydney, New South Wales, Australia.
Lucy SalmonNorth Sydney Orthopaedic Research Group, Sydney, New South Wales, Australia.ORCID 0000-0002-0548-8573
Ka MartinaNorth Sydney Orthopaedic Research Group, Sydney, New South Wales, Australia.ORCID 0000-0002-7492-0577
Joanna CrightonOrthopaedic Services, The Mater Hospital, Sydney, New South Wales, Australia.
Michael O'SullivanNorth Sydney Orthopaedic Research Group, Sydney, New South Wales, Australia.
North Sydney Orthopaedic and Sports Medicine Centre · AUMater Health Services · AUThe University of Notre Dame Australia · AUUNSW Sydney · AU

Funding

Friends of The Mater Foundation
6 · The paper itself

Abstract

backgroundTo determine the prevalence of opioid use in Australian hip (THA) or knee (TKA) cohort, and its association with outcomes.

methodsAbout 837 primary THA or TKA subjects prospectively completed Oxford Scores, and Knee or Hip Osteoarthritis Outcomes Score(KOOS/HOOS) and opioid use in the previous week before arthroplasty. Subjects repeated the baseline survey at 6 months, with additional questions regarding satisfaction.

resultsOpioid use was reported by 19% preoperatively and 7% at 6 months. Opioid use was 46% at 6 weeks and 10% at 6 months after TKR, and 16% at 6 weeks and 4% at 6 months after THR. Preoperative opioid use was associated with back pain(OR 2.2, P = 0.006), anxiety or depression(OR 1.8, P = 0.001) and Oxford knee scores <30(OR 5.6, P = 0.021) in TKA subjects, and females in THA subjects(OR 1.7, P = 0.04). There was no difference between preoperative opioid users and non-users for satisfaction, or KOOS or HOOS scores at 6 months. 77% of patients taking opioids before surgery had ceased by 6 months, and 3% of preoperative non users reported opioid use at 6 months. Opioid use at 6 months was associated with preoperative use (OR 6.6-14.7, P < 0.001), and lower 6 month oxford scores (OR 4.4-83.6, P < 0.01).

conclusionOne in five used opioids before arthroplasty. Pre-operative opioid use was the strongest risk factor for opioid use at 6 months, increasing odds 7-15 times. Prolonged opioid use was rarely observed in the opioid naïve (<5% TKA and 1% THA). Preoperative opioid use was not associated with inferior outcomes or satisfaction.

Indexed as

Arthroplasty, Replacement, HipArthroplasty, Replacement, KneeOpioid-Related DisordersAnalgesics, OpioidAustraliaFemaleHumansAnalgesics, Opioidarthroplastyhipkneeopioidspain control

Identifiers

PMID36097420
PMCPMC9543592
OpenAlexW4290631495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.